OOIR: Observatory of International Research

Papers

(The H4-Index of Lancet Child & Adolescent Health is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Eliminating hepatitis B: the ball is in our court	875
Child poverty in 2023: inequity in times of crises	325
Paediatric group A streptococcal disease in England: a primary care perspective	215
Correction to Lancet Child Adolesc Health 2024; 8: 482–90	193
Optimised versus standard dosing of vancomycin in infants with Gram-positive sepsis (NeoVanc): a multicentre, randomised, open-label, phase 2b, non-inferiority trial	180
Primaquine for children, once and for all	176
The health and wellbeing case for children's suffrage	175
The WHO Model List of Essential Medicines for Children needs its own identity: the case of psychotropic medicines	167
Gamblification: risks of digital gambling games to adolescents	133
Which children in the USA have access to heroic salvage therapy?	131
Tackling post-discharge mortality in children living in LMICs to reduce child deaths	131
Effect of the COVID-19 pandemic on adolescent mental health and substance use up to March, 2022, in Iceland: a repeated, cross-sectional, population-based study	130
Preventing reproductive coercion in adolescence	128
Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniae colonisation in children in South Africa: a single-centre, open-label, randomis	118
Tackling childhood cancer in sub-Saharan Africa	110
Current treatment outcomes of congenital heart disease and future perspectives	106
Obesity-related asthma in children and adolescents	99
The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis	97
Just getting bi?	93
Self-asphyxial behaviour in adolescents	90
Social determinants, inequality, and autism	89
New fellows of the UK Academy of Medical Sciences	89
Noma: a neglected oro-facial childhood disease	85
Correction to Lancet Child Adolesc Health 2022; 6: 150–57	82
Correction to Lancet Child Adolesc Health 2023; 7: 684–85	77

European clinical trials in paediatric radiation oncology	75
Medically cleared and waiting for healing to begin	73
Adolescents and the International Conference on Population and Development at 30	72
Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands	71
Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study	66
Trajectories of airflow limitation from childhood to early adulthood: an analysis of six population-based birth cohorts	65
Rare and severe adverse events in children with inflammatory bowel disease: analysis of data from the PIBD-SETQuality Safety Registry	59
A call to action: children's hospitals, child health, and the climate crisis	57
Investing in childhood cancer registries to drive progress	57
Adolescent girls at the intersection of poverty, migration, and gender	57
Growth of children who are HIV-exposed but uninfected: a systematic review and meta-analysis	55
Neonatal research outcomes: the ethical imperative to change attitudes	52
Trust, but verify: a new potential association between food allergy and asthma in children	51
Short-term and long-term risk of mortality and neurodevelopmental impairments after bacterial meningitis during infancy in children in Denmark and the Netherlands: a nationwide matched cohort study	51
Coping with and challenging the impacts of COVID-19	49
The importance of sleep for adolescents' long-term development	49
Digital media and mental health: understanding the evidence	49
“As we grieved, we grew”	48
Thank you to The Lancet Child & Adolescent Health's statistical and peer reviewers in 2023	47
Correction Lancet Child Adolesc Health 2023; 7: 588–98	47
When vaccine adverse event reporting generates hope, not fear	46